CHFR is methylated in 45 % of human invasive ESCC and infrequently methylated in esophageal early lesions, suggesting that CHFR methylation may serve as a late stage marker in ESCC. The gene discussed is CHFR; the disease is esophageal squamous cell carcinoma.